A 67-year-old man developed *Saccharomyces cerevisiae* infection, oral mucosal lesions and geographical tongue during treatment with enoxaparin sodium, and off label treatment with azithromycin, ceftriaxone, cotrimoxazole, hydroxychloroquine and meropenem for COVID-19 infection \[*routes not stated*\].

The man was admitted to a hospital in Brazil on 31 March 2020 due to diarrhoea, fever, dyspnoea on exertion and respiratory symptoms. His history was significant for coronary artery disease, systemic hypertension, autosomal dominant polycystic kidney disease and kidney transplant. His ongoing medications included unspecified immunosuppressant therapy (started after kidney transplantation) and enoxaparin sodium \[Clexane\] 20 mg/day as pharmacological prophylaxis for pulmonary venous thromboembolism. Following admission, he was diagnosed with COVID-19 infection. After pulmonary exams, he was shifted to ICU for initiation of supplemental oxygen. Later, he developed respiratory failure, requiring orotracheal intubation. Subsequently, off label treatment was started with hydroxychloroquine 400 mg/day \[hydroxychloroquine sulfate; Reuquinol\], azithromycin 500 mg/day \[Zitromax\] and ceftriaxone 2 g/day for 7 days \[ceftriaxone-sodium\]. Also, due to suspicion of mechanical ventilation related pneumonia and worsening of WBC count, additional antibiotic therapy was started with meropenem 1000mg 8/8hs \[Meronem\], cotrimoxazole \[Bactrim; sulfamethoxazole/trimethoprim 400mg/80mg\] 1.5 ampule 8/8hs for 10 days. After that, he underwent tracheostomy, and haemodialysis was initiated with recovery of renal function. He exhibited good recovery and the possibility of spontaneous breathing. At this time, the previously ongoing immunosuppressants and enoxaparin sodium 60 mg/day were re-started. However, persistent oral lesions were noted despite treatment with fluconazole and nystatin \[*exact duration of treatment to reaction onset not stated*\]. Eventually, on day 24 of hospitalisation (24 April 2020), dentists were consulted due to persistent white plaque on the tongue dorsum. During examinations, the dentists also noted multiple pinpoint yellowish ulcers on the tongue dorsum resembling the late stage of herpetic recurrent oral lesions. Additionally, a nodule was located on the lower lip that was around 1cm in diameter, consistent with possible reactive lesion fibroma (confirmed with his pre-existing conditions). The tongue scrape culture showed Saccharomyces cerevisiae. His saliva was extremely viscous.

The man\'s antifungal therapy (fluconazole and nystatin) were continued. He was also prescribed chlorhexidine digluconate alcohol-free mouth rinse and daily application of hydrogen peroxide. He was also instructed to maintain oral hygiene. After 2 weeks, the white lesions on the tongue dorsum improved. During repeat intraoral examinations, asymptomatic severe geographic tongue was noted. After ICU discharge, a prompt recovery was noted in his symptoms. His ongoing antibiotics were also stopped and oxygen requirement decreased. On 14 May 2020, he was discharged from the hospital (after 44 days of hospital stay). After 10 days (25 May 2020), he sent an intra oral image that showed improvement in the geographic tongue with slightly erythematous area near the right palentine tonsil, but he was asymptomatic. The oral mucosal lesions and geographical tongue were considered as possibly related to COVID-19 infection or the treatment course.
